SFRP1 and breast cancer: SFRP1 is an antagonist of the oncogenic WNT signaling pathway [108], and miR-93-3p and miR-105 were reported to suppress SFRP1 expression to promote breast cancer cell stemness, chemoresistance, and metastases [109].